Health Care & Life Sciences » Pharmaceuticals | Chong Kun Dang Pharmaceutical Corp.

Chong Kun Dang Pharmaceutical Corp.

Chong Kun Dang Pharmaceutical Corp.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW4954.46
Market Cap
KRW938.02 B
Shares Outstanding
10.37 M
Public Float
5.92 M

Profile

Address
8 Chungjeong-ro
Seoul SL 03742
Korea, Republic Of
Employees -
Website http://www.ckdpharm.com
Updated 07/08/2019
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetic, antivirus, beta-blocking, anti-hyperlipidemia and others. The company was founded on November 2, 2013 and is headquartered in Seoul, South Korea.

Financials

View All

Young-Ju Kim
President, Chief Executive Officer & Director
Ki-Won Kim
Director & Head-Development